Showing results (151-160 of 258) with videos related to

Sort By:
Pageof 26
Hormones & Cancer|January 18, 2018
Harnessing a Different Dependency: How to Identify and Target Androgen Receptor-Positive Versus Quadruple-Negative Breast CancerJessica L Christenson, Jane B Trepel, Haythem Y Ali, et al.
Molecular Pharmacology|December 26, 2001
Aryl hydrocarbon receptor mediates sensitivity of MCF-7 breast cancer cells to antitumor agent 2-(4-amino-3-methylphenyl) benzothiazoleAndrea I Loaiza-Pérez, Valentina Trapani, Curtis Hose, et al.
The EMBO Journal|October 9, 2003
CHIP activates HSF1 and confers protection against apoptosis and cellular stressQian Dai, Chunlian Zhang, Yaxu Wu, et al.
Cancer|April 30, 2009
Hereditary kidney cancer: unique opportunity for disease-based therapyW Marston Linehan, Peter A Pinto, Gennady Bratslavsky, et al.
Cancer Research|May 23, 2019
RNA Sequencing of the NCI-60: Integration into CellMiner and CellMiner CDBWilliam C Reinhold, Sudhir Varma, Margot Sunshine, et al.
The FEBS Journal|November 11, 2005
Chromosomal protein HMGN1 modulates the expression of N-cadherinYaffa R Rubinstein, Takashi Furusawa, Jae-Hwan Lim, et al.
Cancer Research|February 4, 2016
Effects of Anticancer Drugs on Chromosome Instability and New Clinical Implications for Tumor-Suppressing TherapiesHee-Sheung Lee, Nicholas C O Lee, Natalay Kouprina, et al.
Molecular Cell|January 16, 2007
An acetylation site in the middle domain of Hsp90 regulates chaperone functionBradley T Scroggins, Kenneth Robzyk, Dongxia Wang, et al.
Bioorganic & Medicinal Chemistry Letters|February 6, 2007
A non-toxic Hsp90 inhibitor protects neurons from Abeta-induced toxicitySabah Ansar, Joseph A Burlison, M Kyle Hadden, et al.
Leukemia & Lymphoma|October 1, 2016
Ganetespib, an HSP90 inhibitor, kills Epstein-Barr virus (EBV)-infected B and T cells and reduces the percentage of EBV-infected cells in the bloodAmber Shatzer, Mir A Ali, Mayra Chavez, et al.
Pageof 26